Page 16 - Read Online

Zhao et al. Microbiome Res Rep. 2025;4:28 https://dx.doi.org/10.20517/mrr.2025.12 Page 11 of 13

Availability of data and materials
Not applicable.

Financial support and sponsorship
This work was supported by grants from the National Natural Science Foundation of China (82170583 and
81900510) and the National Key Research and Development Program of China (2021YFC2701900).

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2025.

REFERENCES
1. Loomba R, Friedman SL, Shulman GI. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell.
2021;184:2537-64. DOI PubMed
2. Miao L, Targher G, Byrne CD, Cao YY, Zheng MH. Current status and future trends of the global burden of MASLD. Trends
Endocrinol Metab. 2024;35:697-707. DOI PubMed
3. Chan KE, Koh TJL, Tang ASP, et al. Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-
analysis and systematic review of 10 739 607 individuals. J Clin Endocrinol Metab. 2022;107:2691-700. DOI PubMed
4. Sharpton SR, Schnabl B, Knight R, Loomba R. Current concepts, opportunities, and challenges of gut microbiome-based personalized
medicine in nonalcoholic fatty liver disease. Cell Metab. 2021;33:21-32. DOI PubMed PMC
5. Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on
disease. Nat Rev Microbiol. 2023;21:236-47. DOI PubMed
6. Lee MH, Nuccio SP, Mohanty I, et al. How bile acids and the microbiota interact to shape host immunity. Nat Rev Immunol.
2024;24:798-809. DOI PubMed
7. Perino A, Schoonjans K. Metabolic messengers: bile acids. Nat Metab. 2022;4:416-23. DOI PubMed
8. Foley MH, Walker ME, Stewart AK, et al. Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth
in the murine gut. Nat Microbiol. 2023;8:611-28. DOI PubMed PMC
9. Jia B, Park D, Hahn Y, Jeon CO. Metagenomic analysis of the human microbiome reveals the association between the abundance of
gut bile salt hydrolases and host health. Gut Microbes. 2020;11:1300-13. DOI PubMed PMC
10. Sun L, Zhang Y, Cai J, et al. Bile salt hydrolase in non-enterotoxigenic Bacteroides potentiates colorectal cancer. Nat Commun.
2023;14:755. DOI PubMed PMC
11. Smirnova E, Muthiah MD, Narayan N, et al. Metabolic reprogramming of the intestinal microbiome with functional bile acid changes
underlie the development of NAFLD. Hepatology. 2022;76:1811-24. DOI PubMed PMC
12. Begley M, Hill C, Gahan CGM. Bile salt hydrolase activity in probiotics. Appl Environ Microbiol. 2006;72:1729-38. DOI PubMed
PMC
13. Xu F, Hu XJ, Singh W, Geng W, Tikhonova IG, Lin J. The complex structure of bile salt hydrolase from Lactobacillus salivarius
reveals the structural basis of substrate specificity. Sci Rep. 2019;9:12438. DOI PubMed PMC
14. Rimal B, Collins SL, Tanes CE, et al. Bile salt hydrolase catalyses formation of amine-conjugated bile acids. Nature. 2024;626:859-
63. DOI PubMed PMC
15. Bustos AY, de Valdez GF, Fadda S, Taranto MP. New insights into bacterial bile resistance mechanisms: the role of bile salt hydrolase
and its impact on human health. Food Res Int. 2018;112:250-62. DOI PubMed
16. Song Z, Cai Y, Lao X, et al. Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on
worldwide human gut microbiome. Microbiome. 2019;7:9. DOI PubMed PMC
17. Zhong XC, Liu YM, Gao XX, et al. Caffeic acid phenethyl ester suppresses intestinal FXR signaling and ameliorates nonalcoholic
fatty liver disease by inhibiting bacterial bile salt hydrolase activity. Acta Pharmacol Sin. 2023;44:145-56. DOI PubMed PMC
18. Zhao Q, Dai MY, Huang RY, et al. Parabacteroides distasonis ameliorates hepatic fibrosis potentially via modulating intestinal bile
acid metabolism and hepatocyte pyroptosis in male mice. Nat Commun. 2023;14:1829. DOI PubMed PMC